However, study of changes in inflammation and oxidative stress in patients with newly diagnosed T2DM who have received a 48-week treatment with insulin sensitizer after intensive insulin therapy has only rarely been reported. The gene discussed is INS; the disease is type 2 diabetes mellitus.